These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29350840)

  • 1. A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.
    Kern RC; Stolovitzky JP; Silvers SL; Singh A; Lee JT; Yen DM; Iloreta AMC; Langford FPJ; Karanfilov B; Matheny KE; Stambaugh JW; Gawlicka AK;
    Int Forum Allergy Rhinol; 2018 Apr; 8(4):471-481. PubMed ID: 29350840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study.
    Forwith KD; Han JK; Stolovitzky JP; Yen DM; Chandra RK; Karanfilov B; Matheny KE; Stambaugh JW; Gawlicka AK
    Int Forum Allergy Rhinol; 2016 Jun; 6(6):573-81. PubMed ID: 26992115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RESOLVE: a randomized, controlled, blinded study of bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis.
    Han JK; Forwith KD; Smith TL; Kern RC; Brown WJ; Miller SK; Ow RA; Poetker DM; Karanfilov B; Matheny KE; Stambaugh J; Gawlicka AK
    Int Forum Allergy Rhinol; 2014 Nov; 4(11):861-70. PubMed ID: 25266981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid-eluting sinus implant for in-office treatment of recurrent nasal polyposis: a prospective, multicenter study.
    Lavigne F; Miller SK; Gould AR; Lanier BJ; Romett JL
    Int Forum Allergy Rhinol; 2014 May; 4(5):381-9. PubMed ID: 24599580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mometasone furoate sinus implant - a new targeted approach to treating recurrent nasal polyp disease.
    Shen J; Welch K; Kern R
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1163-1170. PubMed ID: 30457411
    [No Abstract]   [Full Text] [Related]  

  • 6. Steroid-eluting sinus implant for in-office treatment of recurrent polyposis: a pharmacokinetic study.
    Ow R; Groppo E; Clutter D; Gawlicka AK
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):816-22. PubMed ID: 25256638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis.
    Stolovitzky JP; Kern RC; Han JK; Forwith KD; Ow RA; Wright SK; Gould A; Matheny KE; Karanfilov B; Huang S; Stambaugh JW; Gawlicka AK
    Am J Rhinol Allergy; 2019 Sep; 33(5):545-558. PubMed ID: 31117809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mometasone furoate-impregnated biodegradable nasal dressing on endoscopic appearance in healing process following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study.
    Zhao KQ; Yu YQ; Yu HM
    Int Forum Allergy Rhinol; 2018 Nov; 8(11):1233-1241. PubMed ID: 30281941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different types of intranasal steroids for chronic rhinosinusitis.
    Chong LY; Head K; Hopkins C; Philpott C; Burton MJ; Schilder AG
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011993. PubMed ID: 27115215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Budget Impact of a Steroid-Eluting Sinus Implant Versus Sinus Surgery for Adult Chronic Sinusitis Patients with Nasal Polyps.
    Ernst FR; Imhoff RJ; DeConde A; Manes RP
    J Manag Care Spec Pharm; 2019 Aug; 25(8):941-950. PubMed ID: 30843454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mometasone furoate nasal spray in the treatment of nasal polyposis in Chinese patients: a double-blind, randomized, placebo-controlled trial.
    Zhou B; He G; Liang J; Cheng L; Mehta A; Liu S; Yu W; Wang Z; Han D
    Int Forum Allergy Rhinol; 2016 Jan; 6(1):88-94. PubMed ID: 26575524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioabsorbable steroid-releasing implants in the frontal sinus ostia: a pooled analysis.
    Singh A; Luong AU; Fong KJ; Ow RA; Han JK; Gerencer R; Stolovitzky JP; Stambaugh JW; Raman A
    Int Forum Allergy Rhinol; 2019 Feb; 9(2):131-139. PubMed ID: 30431709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis.
    Stjärne P; Mösges R; Jorissen M; Passàli D; Bellussi L; Staudinger H; Danzig M
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):179-85. PubMed ID: 16490876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis.
    Small CB; Hernandez J; Reyes A; Schenkel E; Damiano A; Stryszak P; Staudinger H; Danzig M
    J Allergy Clin Immunol; 2005 Dec; 116(6):1275-81. PubMed ID: 16337459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
    Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
    J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP.
    Bachert C; Zinreich SJ; Hellings PW; Mullol J; Hamilos DL; Gevaert P; Naclerio RM; Amin N; Joish VN; Fan C; Zhang D; Staudinger H; Pirozzi G; Graham NMH; Khan A; Mannent LP
    Rhinology; 2020 Feb; 58(1):10-17. PubMed ID: 31671432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of steroid-releasing sinus implants on postoperative medical and surgical interventions: an efficacy meta-analysis.
    Han JK; Marple BF; Smith TL; Murr AH; Lanier BJ; Stambaugh JW; Mugglin AS
    Int Forum Allergy Rhinol; 2012; 2(4):271-9. PubMed ID: 22550039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, feasibility, and efficacy of placement of steroid-eluting bioabsorbable sinus implants in the office setting: a prospective case series.
    Matheny KE; Carter KB; Tseng EY; Fong KJ
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):808-15. PubMed ID: 25224654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps.
    Sindwani R; Han JK; Soteres DF; Messina JC; Carothers JL; Mahmoud RA; Djupesland PG
    Am J Rhinol Allergy; 2019 Jan; 33(1):69-82. PubMed ID: 30477309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.